Reduced Urgency
Restored Sensation
Improved Capacity
Reduced Leaks
Reduced Frequency
Need For Fewer Catheters
Neurogenic bladder (NB) is the most common comorbidity that people experience after paralysis,
stroke or alongside MS. It has the largest impact on their quality of life. Surveys suggest that
individuals living with paralysis rate improvement in bladder, bowel and sexual function as a higher
priority than restoration of their ability to walk, or even resolution of chronic pain.
Introducing Spinal COrd Neuromodulation (SCONETM) therapy: an adult device that treats urinary incontinence allowing people living with neurogenic bladder due to spinal cord injury, multiple sclerosis and stroke to live their lives on their own terms. It is simple to use, and results in lasting functional improvement.
SCONE has received FDA Breakthrough Device Designation, meaning there is no similar competitive device on the market and the proposed therapy is significantly better than current standard of care (SoC).
How it works:
SCONE therapy focuses on five aspects – urgency, frequency, sensation, capacity and incontinence – no current SoC therapy can address all of these simultaneously.
⦁ SCONE™ Therapy is delivered through comfortable hydrogel electrode pads placed on the skin over specific regions of the spinal column
⦁ Trains the spinal cord and brain to minimize bladder control issues caused by NB
⦁ Treatment consists of 60 minute sessions, 2x/week for 12 weeks
Treatment Protocol
SCONE™ Therapy is delivered through comfortable hydrogel electrode pads that are placed on the skin over specific regions of the spinal column.
SCONE™ Trains the spinal cord and Brain to minimize the bladder control issues caused by neurogenic bladder.